0001753926-25-001126.txt : 20250710 0001753926-25-001126.hdr.sgml : 20250710 20250710161520 ACCESSION NUMBER: 0001753926-25-001126 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250710 DATE AS OF CHANGE: 20250710 EFFECTIVENESS DATE: 20250710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pelthos Therapeutics Inc. CENTRAL INDEX KEY: 0001919246 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 863335449 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551333 FILM NUMBER: 251116475 BUSINESS ADDRESS: STREET 1: 4020 STIRRUP CREEK DRIVE STREET 2: SUITE 110 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-908-2422 MAIL ADDRESS: STREET 1: 4020 STIRRUP CREEK DRIVE STREET 2: SUITE 110 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Channel Therapeutics Corp DATE OF NAME CHANGE: 20241118 FORMER COMPANY: FORMER CONFORMED NAME: Chromocell Therapeutics Corp DATE OF NAME CHANGE: 20220323 D 1 primary_doc.xml X0708 D LIVE 0001919246 Pelthos Therapeutics Inc. 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC NORTH CAROLINA 27703 919-908-2422 NEVADA Channel Therapeutics Corporation Chromocell Therapeutics Corporation Channel Therapeutics Corp Chromocell Therapeutics Corp Corporation true 2021 Scott Plesha 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Executive Officer Director Chief Executive Officer and President Francis Knuettel II 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Executive Officer Chief Financial Officer, Treasurer and Secretary Sai Rangarao 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Executive Officer Chief Commercial Officer Matthew Pauls 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Director Peter Greenleaf 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Director Todd Davis 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Director Richard Baxter 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Director Ezra Friedberg 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Director Richard Malamut 4020 Stirrup Creek Drive Suite 110 Durham NC NORTH CAROLINA 27703 Director Pharmaceuticals Decline to Disclose 06b false 2025-07-01 false true true true true Series A Convertible Preferred Stock, par value $0.0001 per share, convertible into shares of the Company's common stock, par value $0.0001 per share. true 0 50100000 50100000 0 Represents a purchase price consisting of (i) the conversion of approximately $0.1M payable under an outstanding convertible note issued by the Company and (ii) an aggregate of $33,815,252 in shares of Series A Preferred Stock and Common Stock. false 13 0 0 0 false Pelthos Therapeutics Inc. /s/ Francis Knuettel II Francis Knuettel II Chief Financial Officer, Treasurer and Secretary 2025-07-10